Hugh S. Mason

12.4k citations

124 papers · 9.1k indexed · 1 hit paper · h-index 50

Biotechnology top 0.01%
Molecular Biology top 0.5%
Plant Science top 0.5%
Infectious Diseases top 0.5%
Immunology top 2%

Co-authors: Charles J. Arntzen John E. Mullet John D. Clements Yasmin Thanavala D. Lam Zhong Huang Lee J. Richter Qiang Chen
Topics: Transgenic Plants and Applications (92 papers)Plant tissue culture and regeneration (56 papers)CRISPR and Genetic Engineering (28 papers)
Cited by: Biotechnology Molecular Biology Infectious Diseases
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Australia South Korea

In The Last Decade

Hugh S. Mason

122 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of hepatitis B surface antigen in transgenic plants.

1992 505 citations Hugh S. Mason, Charles J. Arntzen et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Hugh S. Mason

Since Specialization

Citations

This map shows the geographic impact of Hugh S. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh S. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh S. Mason more than expected).

Fields of papers citing papers by Hugh S. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh S. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh S. Mason. The network helps show where Hugh S. Mason may publish in the future.

Co-authorship network of co-authors of Hugh S. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh S. Mason. A scholar is included among the top collaborators of Hugh S. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh S. Mason. Hugh S. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recombinant immune complexes as vaccines against infectious diseases 2024 ·Trends in biotechnology ·Mi‐Young Kim,Hugh S. Mason,Julian K‐C.,Rajko Reljić	3
2	Enhanced binding and inhibition of SARS‐CoV‐2 by a plant‐derived ACE2 protein containing a fused mu tailpiece 2023 ·Biotechnology Journal ·Sohee Lim,Hyung‐Jun Kwon,Dae Gwin Jeong,(unknown),Sang‐Hee Lee,(unknown),Kyu‐Sun Lee,Young Bae Ryu,Hugh S. Mason,(unknown),(unknown),Suk‐Yoon Kwon	2
3	A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice 2023 ·Frontiers in Immunology ·Andrew G. Diamos,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jacquelyn Kilbourne,Ian B. Hogue,Hugh S. Mason	1
4	HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy 2022 ·EBioMedicine ·Jennifer M. Zerbato,Anchalee Avihingsanon,Kasha P. Singh,Wei Zhao,Claire Deléage,Elias P. Rosen,Mackenzie L. Cottrell,Ajantha Rhodes,Ashanti Dantanarayana,Carolin Tumpach,Surekha Tennakoon,Megan Crane,David J. Price,Sabine Braat,Hugh S. Mason,Michael Roche,Angela D. M. Kashuba,Peter Revill,Jennifer Audsley,Sharon R. Lewin	18
5	Production of IgG Fusion Proteins Transiently Expressed in <em>Nicotiana benthamiana</em> 2021 ·Journal of Visualized Experiments ·(unknown),(unknown),(unknown),Andrew G. Diamos,(unknown),Tsafrir S. Mor,Hugh S. Mason	2
6	Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection 2020 ·PLoS Pathogens ·Kasha P. Singh,Jennifer M. Zerbato,Wei Zhao,Sabine Braat,Claire Deléage,(unknown),Hugh S. Mason,Ashanti Dantanarayana,Ajantha Rhodes,Jake W. Rhodes,(unknown),Andrew N. Harman,Peter Revill,Megan Crane,Jacob D. Estes,Anchalee Avihingsanon,Sharon R. Lewin,Jennifer Audsley	27
7	A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant 2020 ·Frontiers in Immunology ·Andrew G. Diamos,(unknown),Haiyan Sun,(unknown),Jacquelyn Kilbourne,Qiang Chen,Hugh S. Mason	14
8	Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression 2019 ·Virology ·(unknown),Vitina Sozzi,Hugh S. Mason,Stephen Locarnini,Winita Hardikar,Peter Revill	9
9	Transient Expression of Lumbrokinase (PI239) in Tobacco (Nicotiana tabacum) Using a Geminivirus‐Based Single Replicon System Dissolves Fibrin and Blood Clots 2017 ·Evidence-based Complementary and Alternative Medicine ·(unknown),Nan Wang,Edwin L. Cooper,(unknown),(unknown),Hugh S. Mason,(unknown),(unknown)	6
10	Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves 2016 ·PLoS ONE ·Maryam Zahin,Joongho Joh,(unknown),(unknown),Hugh S. Mason,Heribert Warzecha,Shin‐je Ghim,Donald M. Miller,Nobuyuki Matoba,A. Bennett Jenson	29
11	Spurious polyadenylation of Norovirus Narita 104 capsid protein mRNA in transgenic plants 2011 ·Plant Molecular Biology ·Lolita G. Mathew,Bryan Maloney,Naokazu Takeda,Hugh S. Mason	10
12	Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana 2011 ·Plant Biotechnology Journal ·Waranyoo Phoolcharoen,Seong Hee Bhoo,Huafang Lai,Julian K‐C.,Charles J. Arntzen,Qiang Chen,Hugh S. Mason	110
13	Agrobacterium-Mediated Viral Vector-Amplified Transient Gene Expression in Nicotiana glutinosa Plant Tissue Culture 2007 ·Biotechnology Progress ·(unknown),Hugh S. Mason,Wayne R. Curtis	18
14	Production of Rotavirus-Like Particles in Tomato ( Lycopersicon esculentum L.) Fruit by Expression of Capsid Proteins VP2 and VP6 and Immunological Studies 2006 ·Viral Immunology ·(unknown),Fernando Esquivel‐Guadarrama,(unknown),(unknown),Susana López,Carlos F. Arias,Roberto Ruíz‐Medrano,Hugh S. Mason,Tsafrir S. Mor,Lee J. Richter,Charles J. Arntzen,Miguel Á. Gómez-Lim	37
15	Challenges in creating a vaccine to prevent hepatitis E 2004 ·Vaccine ·Bryan Maloney,Naokazu Takeda,Yuriko Suzaki,Yasushi Ami,Tiancheng Li,Tatsuo Miyamura,Charles J. Arntzen,Hugh S. Mason	21
16	Localization of a bacterial protein in starch granules of transgenic maize kernels 2003 ·Proceedings of the National Academy of Sciences ·Rachel Chikwamba,M. Paul Scott,(unknown),Hugh S. Mason,Kan Wang	77
17	Engineering of single chain antibodies selected from a phage display library into human IgGs that recognise gonadotrophin surge-attenuating factor (GnSAF) bioactivity 2002 ·(unknown),Wayne C. Harris,Hugh S. Mason,Paul Fowler	1
18	Transgenic tobacco plants carrying a baculovirus enhancin gene slow the development and increase the mortality of Trichoplusia ni larvae 2002 ·Plant Cell Reports ·Jianguo Cao,Hamdy Ibrahim,Juan J. García,Hugh S. Mason,(unknown),Elizabeth D. Earle	11
19	Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine 2002 ·Trends in Molecular Medicine ·Hugh S. Mason,Heribert Warzecha,Tsafrir S. Mor,Charles J. Arntzen	163
20	Coregulation of Soybean Vegetative Storage Protein Gene Expression by Methyl Jasmonate and Soluble Sugars 1992 ·PLANT PHYSIOLOGY ·Hugh S. Mason,Daryll B. DeWald,Robert A. Creelman,John E. Mullet	101

About Hugh S. Mason

Hugh S. Mason is a scholar working on Biotechnology, Immunology and Molecular Biology, having authored 124 papers that have together received 9.1k indexed citations. Recurring topics across this work include Transgenic Plants and Applications (92 papers), Plant tissue culture and regeneration (56 papers) and CRISPR and Genetic Engineering (28 papers). The work is most often cited by research in Biotechnology (6.6k citations), Molecular Biology (6.3k citations) and Infectious Diseases (1.6k citations). Hugh S. Mason has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Charles J. Arntzen, John E. Mullet, John D. Clements, Yasmin Thanavala, D. Lam, Zhong Huang, Lee J. Richter, Qiang Chen, Carol O. Tacket and Mary K. Estes. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact